Related Experiment Video
Updated: Jul 25, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Cyclosporine-induced erythromelalgia
Francisco Caiza-Zambrano1, Julio Galarza2, Mauricio Benetti2
1Department of Neurology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina pancho_jcz@hotmail.com.
Abstract:
Erythromelalgia is a rare syndrome characterised by recurrent erythema, heat and burning pain in the extremities. There are two types: primary (genetic) and secondary (toxic, drug-related or associated with other diseases). We report a 42-year-old woman who developed erythromelalgia after taking cyclosporine for myasthenia gravis. Although exact mechanism for this rare adverse effect is unclear, it is reversible, and so clinicians should be aware of the association . Additional use of corticosteroids could aggravate cyclosporine's toxic effects.
Related Concept Videos
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Myocarditis II: Clinical Features and Diagnostic Tests
Nephrotic Syndrome I : Introduction
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Cycloaddition Reactions: MO Requirements for Thermal Activation

